FEDRILATE

Fedrilate is an antitussive reducing cough reflex sensitivity. Side effects include dizziness, drowsiness, and mild GI discomfort. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 9abd7ac648f6 Category: Tag:

Product Description


Mechanism of Action

Fedrilate is an antitussive agent with central coughsuppression activity. It modulates medullary cough centers without significant opioid receptor interaction, making it useful in nonopioid coughcontrol studies.

Benefits and Advantages

Used in coughreflex modelling, centralnervoussystem signalmodulation research, antitussive SAR studies, and airwayneurophysiology assays.

Side Effects and Risks

Risks include mild sedation, dizziness, GI upset and rare allergic reactions. Handle with CNSactive antitussive precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C12H17NO3

Molecular Weight

347.4 g/mol

CAS Number

23271-74-1

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Fedrilate; Fedrilato; 23271-74-1; Fedrilatum; Gotas binelli

IUPAC/Chemical Name

4-morpholin-4-ylbutan-2-yl 4-phenyloxane-4-carboxylate

InChl Key

RDEOYUSTRWNWLX-UHFFFAOYSA-N

InChl Code

InChI=1S/C20H29NO4/c1-17(7-10-21-11-15-24-16-12-21)25-19(22)20(8-13-23-14-9-20)18-5-3-2-4-6-18/h2-6,17H,7-16H2,1H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/31796;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download